More importantly, higher levels of plasma natural anti-NMDAR1 autoantibodies are associated with slower cognitive decline in AD patients as shown in MMSE and other cognitive tests, suggesting that natural anti-NMDAR1 autoantibodies may be neuroprotective. This evidence concerns the gene GRIN1 and Alzheimer disease.